Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients

Bone Marrow Transplantation

Volumn 27, Issue 8, 2001, Pages 877-881

  Konoplev, S ^a   Champlin, R E ^a   Giralt, S ^a   Ueno, N T ^a   Khouri, I ^a   Raad, I ^a   Rolston, K ^b   Jacobson, K ^b   Tarrand, J ^a   Luna, M ^a   Nguyen, Q ^b   Whimbey, E ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Autologous bone marrow transplantation; Cytomegalovirus; Pneumonia

Indexed keywords

ACICLOVIR; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; THIOTEPA;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD AUTOTRANSFUSION; CONTAMINATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG RESPONSE; EXPERIENCE; HEMATOLOGIC DISEASE; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; NEUTROPENIA; OROPHARYNX; PNEUMONIA; PRIORITY JOURNAL; RECIPIENT; RESPIRATORY FAILURE; RISK FACTOR; SERODIAGNOSIS; SOLID TUMOR; SURVIVAL; TIME;

ADULT; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS; TRANSPLANTATION, AUTOLOGOUS; VIRUS ACTIVATION;

EID: 17844373538     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702877     Document Type: Article

References (20)

1. Interstitial pneumonitis following autologous bone marrow transplantation
2. Nonbacterial nonfungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high-dose chemotherapy without total-body irradiation
3. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation
4. Interstitial pneumonitis following autologous bone marrow transplantation
5. Cytomegalovirus infection after autologous bone marrow transplantation: Occurrence of cytomegalovirus disease and effect on engraftment
6. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy
7. Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients
8. Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation
9. Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation
10. Cytomegaloviremia after autografting for leukemia: Clinical significance and lack of effect on engraftment
11. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
12. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: No need for surveillance
13. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
14. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation
15. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation
16. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus unscreened blood-bank donors
17. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant
18. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
19. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture
20. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection